Literature DB >> 23916452

Trichomonas vaginalis and associated factors among women living with HIV/AIDS in Amazonas, Brazil.

Leila Cristina Ferreira Silva1, Angélica Espinosa Miranda, Rosieny Santos Batalha, Rossicléia Lins Monte, Sinésio Talhari.   

Abstract

OBJECTIVES: Our goal was to determine the prevalence of Trichomonas vaginalis and its associated factors among women living with HIV attending an AIDS clinic in Manaus, Amazonas, Brazil.
METHODS: Cross-sectional study among women attending an AIDS clinic in Manaus between March and December 2010 for gynecological examination were invited to participate. Enrolled patients answered a face-to-face interview including demographic, behavioral and clinical data. They also underwent a gynecological evaluation and cervical scrape samples were collected for wet mount, Gram stain, culture and cytological analysis. A blood sample was obtained to determine TCD4+ lymphocytes and viral load.
RESULTS: A total of 341 (91.2%) women participated in the study. The prevalence of T. vaginalis was 4.1% (95% CI: 2.0-6.2%). Median age was 32 (interquartile range 27-38) years and median years of schooling was 9.0 (interquartile range 4-11). A total of 165 (53.2%) HIV women were classified as patients with AIDS. In multivariate analyses, squamous intraepithelial lesions in cytology [OR=2.46 (95% CI: 1.31-4.63, p=0.005)] and anal sex practice [OR=3.62 (95% CI: 1.08-12.19, p=0.037)] were associated with T. vaginalis.
CONCLUSIONS: These results highlight that HIV-infected women should be screened for T. vaginalis. The control of this infection may have an impact on preventing reproductive complications among these women.
Copyright © 2013 Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Amazonas; Associated factors; HIV; Trichomonas vaginalis

Mesh:

Year:  2013        PMID: 23916452      PMCID: PMC9427415          DOI: 10.1016/j.bjid.2013.03.006

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   3.257


Sexually transmitted infections (STI) facilitate HIV transmission through direct and biological mechanisms. Early detection and treatment of STI can be an addition to HIV prevention strategies.1, 2 Trichomonas vaginalis (TV) is a flagellate protozoan considered being sexually transmissible, related to low socioeconomic conditions. TV causes a serious discomfort to women. It is associated with adverse pregnancy outcomes, manifested by preterm rupture of membranes, preterm delivery, low-birth-weight infants,4, 5 infertility, and cervical cancer.6, 7 It also increases the transmission of human immunodeficiency virus (HIV).8, 9, 10 Among HIV-1 positive individuals, infection with TV is associated with higher genital HIV-1 levels.10, 11 Antiretroviral therapy decreases genital shedding of HIV-1, but there is some evidence that shedding may still be increased in the presence of genital tract infections. Therefore, it has been shown that the successful treatment of trichomoniasis in antiretroviral naïve women reduces the shedding and genital HIV-1 levels.10, 12 Our goal was to determine the prevalence of TV and describe the associated factors in HIV women attending an AIDS clinic in Manaus, Amazonas, Brazil. This was a cross-sectional study conducted among women living with HIV. Women attending an AIDS outpatient clinic in Manaus for gynecological examination, between March and December 2010, were invited to participate in the study. Enrolled patients answered a face-to-face interview including demographic, behavioral and clinical data. Pregnant and postpartum women were excluded. They also underwent a gynecological evaluation. Cervical scrape samples were collected for wet mount (in which “corkscrew” motility was observed), Gram stain, culture in Diamond medium and cytological analysis. A blood sample was obtained to determine CD4 count and HIV viral load. Data were analyzed using the SPSS 17.0 for Windows. A preliminary analysis was performed using exploratory techniques on the data. Chi-Square, Fisher's exact and Student's t-tests were used. The odds ratio was used as a measure of association, estimated with a 95% confidence interval. Multivariate analysis was performed to estimate effects of independent variables, through the use of logistic regression models. This study was submitted to and approved by the internal review board of the Amazonas Tropical Medicine Foundation (FMTAM). Written consent was given by the patients for their information to be stored in the hospital database and used for research. A total of 341 (91.2%) of 374 women were included in the study. T. vaginalis was detected in 14 cases [4.1% (95% CI: 2.0–6.2%)]. Median age was 32 (interquartile range (IQR): 27–38) years and median years of schooling was 9.0 (IQR 4–11). A total of 165 (53.2%) HIV women were classified as patients with AIDS. Table 1 shows demographic, behavioral and clinical data; 34.9% were younger than 30 years, 25.8% had up to four years of schooling and 56% had a monthly income up to US$180. Regarding sexual behavior 49% reported first intercourse up to 15 years old; 78.3% used condoms regularly in last year; 30.5% reported previous STI; 16.7% were commercial sex workers; and 32.0% reported anal sex. In univariate analysis, only candidiasis (35.7% vs. 15.0%, p = 0.034) and squamous intraepithelial lesions (SIL) in cytology (35.7% vs. 10.4%, p = 0.004) were significantly associated with trichomoniasis.
Table 1

Demographical, behavioral and clinical characteristics of HIV women attending the AIDS clinic in Manaus, Amazonas, Brazil, (n = 341).

Demographic and clinical variablesTV positiven (%)TV negativen (%)p-Value
Age in years
 18–294 (28.6)115 (35.2)0.633
 30–398 (57.1)60 (44.3)
 ≥402 (14.3)67 (20.5)



Education in years
 Up to 45 (35.7)83 (25.4)0.127
 5–86 (42.9)74 (22.6)
 ≥93 (21.4)170 (52.0)



Marital status
 Married/living together8 (57.1)175 (53.5)0.575
 Single/separated/divorced/widow6 (42.9)152 (46.5)



Monthly income
 Up to one BMIa10 (71.4)181 (55.4)0.555
 1.1–3 BMI4 (28.6)116 (35.5)
 More than 3 BMS0 (0)30 (9.1)



Age at first intercourse
 ≤15 years10 (71.4)157 (48.0)0.086
 >15 years4 (28.6)170 (52.0)



Regular condom use
 Yes11 (78.6)256 (78.3)0.980
 No3 (21.4)71 (21.7)



Sex worker
 Yes2 (14.3)55 (16.8)0.803
 No12 (85.7)272 (83.2)



Homosexual relationship
 Yes1 (7.1)16 (4.9)0.678
 No13 (92.9)311 (95.1)



Anal sex intercourse
 Yes7 (50.0)102 (31.2)0.139
 No7 (50.0)225 (68.8)



Previous STI
 Yes3 (21.4)101 (30.9)0.564
 No11 (78.6)226 (69.1)



Candida infection
 Positive5 (35.7)49 (15.0)0.034
 Negative9 (64.3)278 (85.0)



Bacterial vaginosis
 Positive6 (42.9)115 (35.3)0.577
 Negative8 (57.1)212 (64.7)



Oncotic cervical cytology
 Normal9 (64.3)293 (89.6)0.004
 Cancer precursors lesions5 (35.7)34 (10.4)



CD4 counts
 ≤349 cells/mm35 (35.7)171 (52.8)0.211
 350 to higher cells/mm39 (64.3)153 (47.2)



Viral load (copies/mL)
 ≤100011 (78.6)167 (51.1)0.056
 >10003 (21.4)160 (48.9)

One BMI (Brazilian Minimal Salary) = US$180 in 2011.

Demographical, behavioral and clinical characteristics of HIV women attending the AIDS clinic in Manaus, Amazonas, Brazil, (n = 341). One BMI (Brazilian Minimal Salary) = US$180 in 2011. In multivariate analyses, SIL [OR = 2.46 (95% CI: 1.31–4.63, p = 0.005)] and anal sex practice [OR = 3.62 (95% CI: 1.08–12.19, p = 0.037)] were independently associated with TV. The prevalence of TV found in the AIDS clinic in Manaus, Amazonas was 4.1%. This result is in agreement with data described in a study conducted in an AIDS clinic in São Paulo (3.0%), but lower than the reported rate in other Brazilian study conducted in Recife, which investigated genital infection in HIV women and found 20% of TV. TV causes a wide spectrum of symptoms, ranging from a relatively asymptomatic state to severe inflammation and irritation.3, 6 In this study, abnormalities at cytology and reporting anal sex were factors associated with trichomoniasis. Previous studies had described the association between TV and SIL6, 7 and anal sex and higher risk of STI.15, 16 Although the cross-sectional design is not the best design for determining risk factors, its use is justified for assessing the prevalence of and the associated factors for TV among HIV women. It is important to demonstrate the susceptibility of this group of women to the complications of this infection in women's health. In this study, we cannot rule out the possibility of response bias. There is always a general tendency to give socially acceptable answers. STI continue to take an enormous toll on health, particularly on women's reproductive health. In fact, next to complications of pregnancy and childbirth, they are the leading cause of health problems for women of reproductive age.6, 9 The presence of one or more STI increases the risk of becoming infected with HIV by two to nine times. The bidirectional relationship represents a potentially important factor in sustaining the HIV epidemic in populations where TV is endemic and it can also be affected by reproductive health tract infections.2, 8, 9 Health care services for HIV infected women exist and they are able to successfully control the infection and avoid the disease's progression. Although this is promising, there is still much work to be done to identify innovative interventions that refer to the social, cultural and environmental influences of the STI presence in this group. It is also necessary to find better means of access for the prevention of HIV infection, so that effective interventions can be more broadly used.

Conflicts of interest

The authors declare no conflicts of interest.
  15 in total

1.  Sexually transmitted infections and adverse pregnancy outcomes among women attending inner city public sexually transmitted diseases clinics.

Authors:  Hope L Johnson; Khalil G Ghanem; Jonathan M Zenilman; Emily J Erbelding
Journal:  Sex Transm Dis       Date:  2011-03       Impact factor: 2.830

Review 2.  Trichomonas vaginalis: paradigm of a successful sexually transmitted organism.

Authors:  S Rughooputh; P Greenwell
Journal:  Br J Biomed Sci       Date:  2005       Impact factor: 3.829

3.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

Authors:  C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  2001-02-28       Impact factor: 5.226

4.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

5.  Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women.

Authors:  Barbara Van Der Pol; Cynthia Kwok; Bosny Pierre-Louis; Anne Rinaldi; Robert A Salata; Pai-Lien Chen; Janneke van de Wijgert; Francis Mmiro; Roy Mugerwa; Tsungai Chipato; Charles S Morrison
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

6.  Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York city who use drugs.

Authors:  Maureen Miller; Yuyan Liao; Anu Manchikanti Gomez; Charlotte A Gaydos; Delysha D'Mellow
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

7.  Anal intercourse among young heterosexuals in three sexually transmitted disease clinics in the United States.

Authors:  Pamina M Gorbach; Lisa E Manhart; Kristen L Hess; Bradley P Stoner; David H Martin; King K Holmes
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

8.  Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.

Authors:  Patricia Kissinger; Angela Amedee; Rebecca A Clark; Jeanne Dumestre; Katherine P Theall; Leann Myers; Michael E Hagensee; Thomas A Farley; David H Martin
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

9.  A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.

Authors:  Linnet N Masese; Susan M Graham; Ruth Gitau; Nobert Peshu; Walter Jaoko; Jeckoniah O Ndinya-Achola; Kishorchandra Mandaliya; Barbra A Richardson; Julie Overbaugh; R Scott McClelland
Journal:  BMC Infect Dis       Date:  2011-11-03       Impact factor: 3.090

10.  Prior history of sexually transmitted diseases in women living with AIDS in São Paulo, Brazil.

Authors:  Valdir Monteiro Pinto; Mariza Vono Tancredi; Jonathan Eric Golub; Ariane de Castro Coelho; Antonio Tancredi Neto; Angelica Espinosa Miranda
Journal:  Braz J Infect Dis       Date:  2012 May-Jun       Impact factor: 1.949

View more
  4 in total

1.  Prevalence of Trichomonas vaginalis infection among Egyptian women using culture and Latex agglutination: cross-sectional study.

Authors:  Ahmed Mahmoud; Nadine A Sherif; Rana Abdella; Amira R El-Genedy; Abdalla Y El Kateb; Ahmed Nh Askalani
Journal:  BMC Womens Health       Date:  2015-02-07       Impact factor: 2.809

2.  Prevalence, Clinical Criteria and Sociodemographic Predictors of Trichomonas vaginalis Infection in Suspected Egyptian Women, Using Direct Diagnostic Techniques.

Authors:  Atef Hussein Hussein; Mohamed Hussein Saleh; Ibrahim Maged Nagaty; Khaled A Ghieth; Nagat Ahmed El-Azab
Journal:  Iran J Parasitol       Date:  2015 Jul-Sep       Impact factor: 1.012

3.  The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil.

Authors:  Fabiane Aguiar Dos Anjos Gatti; Etienne Ceolan; Fernando Salles Rodrigues Greco; Paula Costa Santos; Gabriel Baracy Klafke; Gisele Rodrigues de Oliveira; Andrea Von Groll; Ana Maria Barral de Martinez; Carla Vitola Gonçalves; Carlos James Scaini
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

4.  Trichomonas vaginalis PREVALENCE AND RISK FACTORS FOR WOMEN IN SOUTHERN BRAZIL.

Authors:  Cíntia Lima Ambrozio; Andréia Saggin Nagel; Sabrina Jeske; Guilherme Cassão Marques Bragança; Sibele Borsuk; Marcos Marreiro Villela
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.